AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Intellia Therapeutics Inc... (NTLA)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

12.15

-0.10 (-0.82%)

At close: Feb 21, 2025, 3:59 PM

12.02

-1.11%

After-hours: Feb 21, 2025, 04:08 PM EST

Intellia Therapeutics Income Statement

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14
Revenue	36.27M	52.12M	33.05M	57.99M	43.1M	30.43M	26.12M	16.48M	6.04M	n/a
Cost of Revenue	8.98M	7.57M	6.89M	150.41M	108.41M	89.11M	67.65M	31.84M	11.17M	1.66M
Gross Profit	27.3M	44.55M	26.16M	-92.41M	-65.31M	-58.68M	-41.53M	-15.36M	-5.13M	-1.66M
Operating Income	-515.29M	-458.16M	-267.85M	-136.58M	-106.37M	-90.87M	-69.56M	-32.16M	-13.41M	-5.23M
Interest Income	49.83M	8.54M	1.28M	2.35M	6.83M	5.53M	2.01M	525K	n/a	n/a
Pretax Income	-481.19M	-474.19M	-267.89M	-134.23M	-99.53M	-85.34M	-67.54M	-31.63M	-13.41M	-14.31M
Net Income	-481.19M	-490.21M	-259.72M	-125.57M	-92.7M	-85.34M	-67.54M	-31.63M	-12.4M	-14.31M
Selling & General & Admin	116.5M	90.31M	71.1M	44.17M	41.06M	32.19M	28.02M	16.8M	8.28M	3.57M
Research & Development	435.07M	419.98M	229.81M	150.41M	108.41M	89.11M	67.65M	31.84M	11.17M	10.74M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	551.57M	510.29M	300.9M	194.58M	149.47M	121.3M	95.67M	48.64M	19.45M	12.65M
Interest Expense	n/a	8.54M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	551.57M	510.29M	300.9M	194.58M	149.47M	121.3M	95.67M	48.64M	19.45M	14.31M
Income Tax	n/a	16.02M	-8.17M	-8.66M	-6.83M	5.53M	-2.99M	-1.1M	-1.01M	n/a
Shares Outstanding (Basic)	88.77M	76.97M	70.89M	55.99M	47.25M	43.07M	36.01M	22.22M	17.66M	485.88K
Shares Outstanding (Diluted)	88.77M	76.97M	70.89M	55.99M	47.25M	43.07M	36.01M	22.22M	17.66M	485.88K
EPS (Basic)	-5.42	-6.37	-3.66	-2.24	-1.96	-1.98	-1.88	-1.42	-0.7	-29.45
EPS (Diluted)	-5.42	-6.37	-3.66	-2.24	-1.96	-1.98	-1.88	-1.42	-0.7	-29.45
EBITDA	-506.31M	-450.59M	-260.96M	-130.27M	-100.78M	-86.41M	-66.56M	-31.05M	-13.08M	-9.54M
Depreciation & Amortization	8.98M	7.57M	6.89M	6.31M	5.59M	4.46M	2.99M	1.1M	328K	4.5K